Chart calendar GENFIT

b7fc.459oJqLs7tQiSYq7-x0sIGS6OhqYeClWcGzZPFoNuyU.otQmEOyGvL5oDf6ImnJaTTv_fiL8FX0vIS-oUCta_RWN8D5h-KGEt3UFzw~dfaee3dc011f500a5086d6bdb4b39d67

Upcoming events on GENFIT

2025-09-21 Q2 2025 Earnings Release
2025-11-19 Q3 2025 Sales and Revenue Release
2026-04-08 Q4 2025 Earnings Release (Projected)
2026-09-29 Q2 2026 Earnings Release (Projected)
2027-04-14 Q4 2026 Earnings Release (Projected)
2027-09-28 Q2 2027 Earnings Release (Projected)

Past events on GENFIT

2025-06-16 Annual General Meeting
2025-05-21 Q1 2025 Sales and Revenue Release
2025-05-10 05:15 European Association for the Study of the Liver Meeting
2025-04-24 16:10 Q4 2024 Earnings Release
2024-11-06 Q3 2024 Sales and Revenue Release
2024-09-19 16:10 Q2 2024 Earnings Release
2024-05-22 04:00 Annual General Meeting
2024-05-13 Q1 2024 Sales and Revenue Release
2024-04-04 16:10 Q4 2023 Earnings Release
2024-02-28 Q4 2023 Sales and Revenue Release
2024-02-07 12:30 Guggenheim Healthcare Talks Biotechnology Conference
2023-11-14 10:00 American Association for the Study of Liver Diseases Conference - Dr. Christopher Bowlus
2023-11-13 16:45 American Association for the Study of Liver Diseases Conference - Abstract No - #484
2023-11-13 13:30 American Association for the Study of Liver Diseases Conference - Dr. Stephen Harrison
2023-11-12 18:30 American Association for the Study of Liver Diseases Conference
2023-11-11 12:30 American Association for the Study of Liver Diseases Conference - Dr. Jennifer Lai
2023-11-09 American Association for the Study of Liver Diseases Conference - Poster No - #2082
2023-11-09 American Association for the Study of Liver Diseases Conference - Poster No - #2100
2023-11-09 American Association for the Study of Liver Diseases Conference - Oral Presentation No - #238
2023-11-09 American Association for the Study of Liver Diseases Conference - Poster No - #2089

Annual results

Fiscal PeriodDecember 2022 2023 2024 2025 2026 2027
Net sales
Million EUR
Released
Forecast
Spread
26,6
17,4
53%
38,2
61,6
-38.07%
70,9
77,4
-8.31%

234


65,9


81,2

EBITDA
Million EUR
Released
Forecast
Spread
-25,5
-35,6
28.55%
-24,9
-38,2
34.76%
5,01
29,4
-82.98%

172


12,1


80,0

EBIT
Million EUR
Released
Forecast
Spread
-27,3
-38,5
29.06%
-26,6
-25,4
-4.81%
3,28
16,8
-80.47%

172


-10,6


5,90

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
-23,8
-34,1
30.02%
-28,5
5,23
-645.39%
1,85
2,70
-31.59%

176


-29,5


-64,3

Net income
Million EUR
Released
Forecast
Spread
-23,7
-42,5
44.21%
-28,9
-21,9
-32.17%
1,51
20,1
-92.51%

36,5


-20,3


-7,03

EPS
EUR
Released
Forecast
Spread
-0,48
-0,96
50%
-0,58
-0,56
-3.66%
0,03
0,26
-88.24%

2,40


-0,20


-0,04

Announcement Date13/04/2304/04/2424/04/25-

Quarterly results

Fiscal PeriodDecember 2023 S1 2023 S2 2024 S1 2024 Q4 2024 S2 2025 Q1 2025 Q2 2025 S1 2025 Q3 2025 Q4 2025 S2
Net sales
Million EUR
Released
Forecast
Spread
15,4
14,3
7.36%
22,8
75,7
-69.87%
61,2
48,3
26.79%
11,2
7,30
53.96%
12,0
23,1
-48.12%
2,80
133
-97.89%

29,5


162


3,47


4,32


7,80

EBIT
Million EUR
Released
Forecast
Spread
-19,3
-24,3
20.51%
-7,28
10,1
-172.3%
31,2
21,1
48.11%



-27,9
-26,8
-4.26%







121








-38,8

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
-20,4
-24,8
17.51%
-8,07
46,4
-117.39%
30,3
22,8
32.93%



-28,5
-27,6
-3.27%







122








-37,7

Net income
Million EUR
Released
Forecast
Spread
-20,9
-16,7
-25.22%
-8,04
9,87
-181.46%
30,3
17,2
76.02%



-28,8
-11,5
-150.47%







109








-37,7

EPS
EUR
Released
Forecast
Spread
-0,42
-0,20
-110%



0,53
0,49
8.16%



-0,50
-0,55
9.09%







2,18








-0,75

Announcement Date20/09/2304/04/2419/09/2424/04/2524/04/2522/05/25-----

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise